-
Ambit Biosciences Corp., San Diego, Calif. Business: Cancer, Autoimmune, Inflammation Date announced: 5/2/13 Type: Private placement To be raised: $25.1 million Shares: TBD Price: TBD Investors: Existing investors Note:…
Published on 5/13/2013
-
AnGes MG Inc. (Tokyo:4563), Osaka, Japan Business: Cardiovascular, Autoimmune, Gene/Cell therapy Date announced: 5/1/13 Type: Private placement To be raised: At least 5.1 billion ($51.2 million) Price prior: 253,600 …
Published on 5/13/2013
-
Heat Biologics Inc., Miami Beach, Fla. Business: Cancer, Inflammation Date announced: 5/6/13 Type: IPO To be raised: Up to $20 million Shares: TBD Price: TBD Underwriter: Aegis Capital
Published on 5/13/2013
-
Omeros Corp. (NASDAQ:OMER), Seattle, Wash. Business: Inflammation, Neurology, Ophthalmic Date announced: 5/9/13 Type: Direct public offering To be raised: $16.2 million Shares: 3.9 million Price: $4.14 Shares …
Published on 5/13/2013
-
PeptiDream Inc., Tokyo, Japan Business: Supply/Service Date announced: 5/8/13 Type: IPO To be raised: Up to 5.2 billion ($52.3 million) Shares: 2.7 million Price: 1,720-1,920 Underwriters: Mizuho; and eight others …
Published on 5/13/2013
-
Vermillion Inc. (NASDAQ:VRML), Austin, Texas Business: Diagnostic Date announced: 5/9/13 Type: Private placement of common stock and warrants To be raised: $13.2 million Shares: 8 million Price: $1.46 Shares outstanding…
Published on 5/13/2013
-
Harvard Apparatus Regenerative Technology Inc., Holliston, Mass. Business: Supply/Service Date announced: 5/1/13 Type: IPO Underwriters: Summer Street; Maxim Group Note: Harvard Bioscience Inc. (NASDAQ:HBIO, Holliston, …
Published on 5/13/2013
-
Cynapsus Therapeutics Inc. (TSX:CTH), Toronto, Ontario Business: Drug delivery, Neurology Date announced: 2/22/13 Type: Private placement of units To be raised: C$6-C$8 million ($6-$7.8 million) Units: 173.9 million …
Published on 3/4/2013
-
Immunovaccine Inc. (TSX-V:IMV), Halifax, Nova Scotia Business: Cancer, Infectious Date announced: 2/27/13 Type: Private placement To be raised: Up to C$2 million ($2 million) Shares: 6.1 million Price: C$0.33 Shares …
Published on 3/4/2013
-
Ablynx N.V. (Euronext:ABLX), Ghent, Belgium Business: Antibodies Date completed: 2/28/13 Type: Private placement Raised: 31.5 million ($41.7 million) Shares: 4.4 million Price: 7.20 Shares after offering: 48.2 million …
Published on 3/4/2013
-
Actinobac Biomed Inc., North Brunswick, N.J. Business: Cancer, Autoimmune Date completed: 2/21/13 Type: Venture financing Raised: $100,000 Investor: Foundation Venture Capital Group
Published on 3/4/2013
-
Bind Biosciences Inc., Cambridge, Mass. Business: Cancer, Drug delivery Date completed: 2/8/13 Type: Venture financing Raised: $8.7 million Investors: Existing investors Note: The company raised $8.7 million of a …
Published on 3/4/2013
-
Brickell Biotech Inc., Miami, Fla. Business: Dermatology, Ophthalmic Date completed: 2/26/13 Type: Venture financing Raised: Not disclosed Investors: Amorepacific Ventures; Palisade Capital; existing investors Note: The…
Published on 3/4/2013
-
Critical Diagnostics, San Diego, Calif. Business: Diagnostic Date completed: 2/25/13 Type: Venture financing Raised: Not disclosed
Published on 3/4/2013
-
DecImmune Therapeutics Inc., Boston, Mass. Business: Cardiovascular, Dermatology Date completed: 2/26/13 Type: Venture financing Raised: $2.3 million Investors: Broadview Ventures; Astellas Venture; HealthCare Ventures
Published on 3/4/2013
-
DelMar Pharmaceuticals Inc. (OTCBB:DMPI), Vancouver, B.C. Business: Cancer Date completed: 2/25/13 Type: Private placement of units Raised: $1.6 million Units: 2 million Price: $0.80 (unit) Shares after offering: 20.7 …
Published on 3/4/2013
-
Dezima Pharma B.V., Naarden, the Netherlands Business: Cardiovascular Date completed: 2/28/13 Type: Venture financing Raised: 4.4 million ($5.8 million) Investor: Agentschap Note: The financing is a loan from Agentschap…
Published on 3/4/2013
-
Dezima Pharma B.V., Naarden, the Netherlands Business: Cardiovascular Date completed: 2/28/13 Type: Venture financing Raised: 9.8 million ($13 million) Investors: Forbion Capital Partners; BioGeneration Ventures; New …
Published on 3/4/2013
-
e-Therapeutics plc (LSE:ETX), Newcastle upon Tyne, U.K. Business: Infectious, Cancer Date completed: 3/1/13 Type: Placing Raised: 40 million ($60.6 million) Shares: 125 million Price: 32p Shares after offering: 263.2 …
Published on 3/4/2013
-
EnteroMedics Inc. (NASDAQ:ETRM), St. Paul, Minn. Business: Endocrine/Metabolic, Gastrointestinal Date completed: 2/22/13 Type: Follow-on Raised: $13.1 million Units: 13.8 million Price: $0.95 (unit) Shares after …
Published on 3/4/2013
-
Glide Pharma Technologies Ltd., Abingdon, U.K. Business: Drug delivery Date completed: 2/26/13 Type: Venture financing Raised: 14 million ($21.2 million) Investors: Invesco; existing investors
Published on 3/4/2013
-
Intersect ENT Inc., Palo Alto, Calif. Business: Infectious Date completed: 2/25/13 Type: Venture financing Raised: Not disclosed Investors: Norwest Venture Partners; Kleiner Perkins Caufield & Byers; U.S. Venture …
Published on 3/4/2013
-
Kala Pharmaceuticals Inc., Waltham, Mass. Business: Ophthalmic, Drug delivery Date completed: 2/28/13 Type: Venture financing Raised: $11.5 million Investors: Crown Venture Fund; Lux Capital; Polaris Venture Partners; …
Published on 3/4/2013
-
NeoGenomics Inc. (NASDAQ:NEO), Fort Myers, Fla. Business: Genomics, Diagnostic, Supply/Service Date completed: 2/28/13 Type: Follow-on Raised: $8.6 million Shares: 2.9 million Price: $3 Shares after offering: 48.1 …
Published on 3/4/2013
-
Oxygen Biotherapeutics Inc. (NASDAQ:OXBT), Morrisville, N.C. Business: Hematology, Diagnostic, Pulmonary Date completed: 2/22/13 Type: Private placement of convertible preferred stock and warrants Raised: $2.1 million …
Published on 3/4/2013